@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:associate . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:00:09.635305"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "with reduced mortality among patients with COVID-19 requiring respiratory support" . rdf:OBJECT-POSITION rdfs:label "204"^^xsd:integer . rdf:PREDICATE rdfs:label "associated" . rdf:PREDICATE-POSITION rdfs:label "[164]" . rdf:SUBJECT rdfs:label "dexamethasone use administered either orally or by intravenous injection at a cumulative dose between 60 mg and 150 mg" . rdf:SUBJECT-POSITION rdfs:label "92"^^xsd:integer . rdfs:ABSTRACT-UID ns2:50 "7hb2qnr0" . rdfs:SENTENCE rdfs:label "In this multicenter observational study, dexamethasone use administered either orally or by intravenous injection at a cumulative dose between 60 mg and 150 mg was associated with reduced mortality among patients with COVID-19 requiring respiratory support." . rdfs:TRIPLE-UID ns3:7hb2qnr0-TRIPLE-ABSTRACT-17 "7hb2qnr0-TRIPLE-ABSTRACT-17" . rdfs:label "patients" . rdfs:label "intravenous" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "e0YUN9Iv5o4IlNB67qUe3ryQ3lbprV9GLTJCTg99iUa4FD1lssVJGidk93IvkFQO6hF6CcJFP+heJz0S7xiLEuAhjyvwPRKq9T0nwe8XwE1JCOE8OlR4/khHDsSp1+be9NJIffkd7Us5usStT5wNMfjvZSU7QLK8ykAH/JHki+U="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:00:09.635305"^^xsd:dateTime; prov:wasAttributedTo . }